Epstein-Barr virus serologic profiles were obtained from 618 patients using an automated platform, including the new BioPlex heterophile assay. When compared with 2 IgM viral capsid antigen (VCA) assays and a predicate heterophile assay, the BioPlex heterophile assay was more likely to be associated with serologic patterns of acute infection.
|Number of pages||3|
|Journal||Diagnostic Microbiology and Infectious Disease|
|State||Published - Jul 1 2008|
- Epstein-Barr Virus
- Infectious serology
- Multiplex testing